Safety and Effectiveness of the HIT Reverse HRS
NCT05357378
This study is recruiting at 5 US sites in 3 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to determine if the use of the HIT Reverse Hip Replacement System is safe and effective in patients undergoing total hip replacement. We will determine whether it is safe and effective by comparing it to the control devices.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Degenerative Joint Disease
- Osteoarthritis, Hip
- Avascular Necrosis of Hip
- Traumatic Arthropathy-Hip
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 50 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Hip Innovation Technology
- Last updated on ClinicalTrials.gov
- September 21, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 3
- Miami Institute for Joint Reconstruction · Miami, FL
- Advent Health Hospital, Carrollwood · Tampa, FL
- Tampa General Health / Florida Orthopedic Institute · Tampa, FL
New Jersey · 1
- Division of Orthopaedic Surgery · Somers Point, NJ
Ohio · 1
- JIS Orthopedics · New Albany, OH
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.